Plunkett Research Online: Nicox

NICOX (NICXF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Nicox SA is an international company specializing in ophthalmology developing innovative solutions aimed at maintaining vision and improving eye health. Nicox's lead program in clinical development is NCX 470, a novel nitric oxide-donating prostaglandin analog for the reduction of intraocular pressu.....



Nicox
Ticker: NICXF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 497245300
Fax: 33 497245399
Address: 2405 route des Dolines
Drakkar 2 -Batiment D
Valbonne
Sophia Antipolis, 06560 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description
Jean-Francois LabbeChairman of the Board/Director
Lauren SilvernailDirector
See More
Nicox SA is an international company specializing in ophthalmology developing innovative solutions aimed at maintaining vision and improving eye health. Nicox's lead program in clinical development is NCX 470, a novel nitric oxide-donating prostaglandin analog for the reduction of intraocular pressu.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: